X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6878) 6878
Publication (788) 788
Book Chapter (75) 75
Dissertation (44) 44
Conference Proceeding (43) 43
Book Review (23) 23
Magazine Article (22) 22
Newspaper Article (10) 10
Trade Publication Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
benzoxazines (2867) 2867
humans (2812) 2812
male (2483) 2483
index medicus (2249) 2249
animals (1975) 1975
hiv infections - drug therapy (1599) 1599
female (1571) 1571
pharmacology & pharmacy (1300) 1300
morpholines - pharmacology (1173) 1173
naphthalenes - pharmacology (1168) 1168
benzoxazines - pharmacology (1161) 1161
benzoxazine (1140) 1140
adult (1127) 1127
rats (1120) 1120
infectious diseases (910) 910
anti-hiv agents - therapeutic use (881) 881
efavirenz (856) 856
benzoxazines - therapeutic use (849) 849
polymer science (821) 821
neurosciences (819) 819
middle aged (727) 727
benzoxazines - administration & dosage (660) 660
hiv (650) 650
reverse transcriptase inhibitors - therapeutic use (610) 610
analysis (605) 605
dose-response relationship, drug (582) 582
immunology (568) 568
mice (563) 563
benzoxazin (557) 557
polymers (556) 556
polybenzoxazines (536) 536
drug therapy, combination (521) 521
pyrazoles - pharmacology (520) 520
piperidines - pharmacology (517) 517
polymerization (504) 504
oxazines - therapeutic use (495) 495
rats, sprague-dawley (480) 480
anti-hiv agents - adverse effects (477) 477
benzoxazines - adverse effects (471) 471
treatment outcome (459) 459
anti-hiv agents - administration & dosage (449) 449
cannabinoids - pharmacology (435) 435
hiv infections - virology (432) 432
benzoxazines - chemistry (430) 430
viral load (423) 423
antiviral agents (418) 418
antiretroviral therapy (411) 411
ring-opening polymerization (409) 409
monomers (400) 400
virology (394) 394
hiv-1 - drug effects (366) 366
cd4 lymphocyte count (361) 361
polybenzoxazine (361) 361
rats, wistar (356) 356
benzoxazines - pharmacokinetics (347) 347
drug interactions (343) 343
chemistry, multidisciplinary (341) 341
time factors (338) 338
article (332) 332
therapy (325) 325
biochemistry & molecular biology (321) 321
microbiology (317) 317
reverse transcriptase inhibitors - adverse effects (316) 316
research (312) 312
nevirapine (308) 308
receptor, cannabinoid, cb1 - agonists (298) 298
resins (298) 298
hiv infection (297) 297
pharmacokinetics (296) 296
receptors, cannabinoid (296) 296
drug therapy (294) 294
chemistry, organic (288) 288
nevirapine - therapeutic use (288) 288
brain (287) 287
cannabinoids (284) 284
hiv-1 (279) 279
thermal properties (273) 273
oxazines - adverse effects (268) 268
reverse transcriptase inhibitors - administration & dosage (264) 264
antiretroviral therapy, highly active (261) 261
cannabinoid (258) 258
endocannabinoids (258) 258
adolescent (254) 254
aged (252) 252
anti-hiv agents - pharmacokinetics (249) 249
receptor, cannabinoid, cb1 - metabolism (249) 249
in vitro techniques (243) 243
tenofovir (241) 241
chemistry, medicinal (237) 237
molecular structure (236) 236
chemistry (233) 233
disease models, animal (233) 233
oxazines (231) 231
lamivudine - therapeutic use (227) 227
curing (226) 226
hiv-1 - genetics (226) 226
young adult (225) 225
thermal stability (223) 223
anti-hiv agents - pharmacology (222) 222
oxazines - administration & dosage (222) 222
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6798) 6798
Chinese (89) 89
German (54) 54
French (28) 28
Spanish (21) 21
Japanese (16) 16
Italian (13) 13
Dutch (9) 9
Russian (8) 8
Korean (4) 4
Czech (2) 2
Portuguese (2) 2
Hungarian (1) 1
Slovak (1) 1
Ukrainian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Polymer Science, Part A: Polymer Chemistry, ISSN 0887-624X, 12/2013, Volume 51, Issue 23, pp. 5075 - 5084
3-Phenyl-3,4-dihydro-2H-1,3-benzoxazine (m sub(1)) underwent cationic ring opening polymerization using BF sub(3).OEt sub(2) in alcoholic solution under mild... 
Benzoxazines
Journal Article
Insulating Materials, ISSN 1009-9239, 10/2013, Volume 46, Issue 5, pp. 52 - 57
Five kinds of benzoxazine precursor containing propargyl group(P-appe, B-appe, P-pla, B-pla and M-pla) were synthesized by Mannich condensation reaction among... 
Benzoxazines
Journal Article
Dalton Transactions, ISSN 1477-9226, 2018, Volume 47, Issue 1, pp. 246 - 250
The reaction of a NiII complex and meta-chloroperoxybenzoic acid (m-CPBA) resulted in the formation of a long-lived NiIII–chlorobenzoate complex that is a... 
Cleavage | Benzoxazines
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 01/2016, Volume 44, Issue 1, pp. 151 - 161
Efavirenz (EFV) is principally metabolized by CYP2B6 to 8-hydroxy-efavirenz (8OH-EFV) and to a lesser extent by CYP2A6 to 7-hydroxy-efavirenz (7OH-EFV). So... 
400 MG | TRIAL | THERAPY | CYP2B6 | HIV | MORPHINE | LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY | MORPHINE-6-GLUCURONIDE | PHARMACOLOGY & PHARMACY | ACTIVE-TRANSPORT | BLOOD-BRAIN-BARRIER | Neurotoxicity Syndromes - genetics | Reverse Transcriptase Inhibitors - blood | Humans | Anti-HIV Agents - cerebrospinal fluid | Glucuronides - cerebrospinal fluid | Cytochrome P-450 CYP2B6 - metabolism | Glucuronides - blood | Reverse Transcriptase Inhibitors - adverse effects | Tandem Mass Spectrometry | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - urine | Cytochrome P-450 CYP3A - genetics | Benzoxazines - pharmacokinetics | Sulfates - blood | HIV Infections - diagnosis | Benzoxazines - blood | Anti-HIV Agents - blood | Reverse Transcriptase Inhibitors - urine | Metabolic Detoxication, Phase II | Hydroxylation | Risk Assessment | Cytochrome P-450 CYP2A6 - genetics | Cytochrome P-450 CYP2B6 - genetics | Anti-HIV Agents - adverse effects | Benzoxazines - cerebrospinal fluid | Benzoxazines - adverse effects | Cytochrome P-450 CYP2A6 - metabolism | Genotype | Glucuronides - urine | Anti-HIV Agents - urine | Reverse Transcriptase Inhibitors - cerebrospinal fluid | Sulfates - cerebrospinal fluid | Metabolomics - methods | Neurotoxicity Syndromes - etiology | Phenotype | Sulfates - urine | Cytochrome P-450 CYP3A - metabolism | Anti-HIV Agents - pharmacokinetics | Metabolic Detoxication, Phase I | Neurotoxicity Syndromes - metabolism | HIV Infections - drug therapy | HIV Infections - metabolism | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55111
textabstractBackground: Antiretroviral treatment (ART) options for young children co-infected with HIV and tuberculosis are limited in resource-poor settings... 
EQUIVALENCE TRIAL | ANTITUBERCULAR THERAPY | EFFICACY | PLASMA-CONCENTRATIONS | AFRICAN CHILDREN | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | INITIAL TREATMENT | RIFAMPICIN | NEVIRAPINE | HIGH PREVALENCE | Coinfection | Benzoxazines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Humans | Child, Preschool | Benzoxazines - adverse effects | Male | Treatment Outcome | CD4 Lymphocyte Count | Viral Load | Benzoxazines - therapeutic use | Anti-HIV Agents - administration & dosage | Tuberculosis - immunology | HIV Infections - immunology | Treatment Failure | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Child | Antiviral agents | Usage | Tuberculosis | HIV patients | Antitubercular agents | Reverse transcriptase inhibitors | Drug therapy | HIV (Viruses) | T cells | HIV infection | Pediatrics | Disease | Nevirapine | Medical records | Infections | Lymphocytes T | Medical diagnosis | Epidemiology | Efavirenz | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Measurement methods | Children | Drug dosages | Age | Public health | Antiretroviral drugs | Pharmacology | CD4 antigen | Descriptive labeling | Hospitals | Convulsions | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Journal Article
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 05/2018, Volume 28, Issue 9, pp. 1629 - 1637
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 04/2009, Volume 19, Issue 4, pp. 300 - 309
Journal Article